Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Veverimer
Veverimer
Tricida’s shares plunge as phase 3 fail seals fate of FDA-rejected kidney disease drug
Fierce Biotech
Mon, 10/24/22 - 11:59 am
Tricida
clinical trial
kidney disease
Veverimer
Tricida sinks as FDA rejection raises prospect of new trial
Fierce Biotech
Tue, 08/25/20 - 10:33 am
Tricida
metabolic acidosis
chronic kidney disease
clinical trials
FDA
Veverimer